These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 25769054)

  • 1. Does prevention pay?
    Meltzer D
    Med Care; 2015 Apr; 53(4):291-2. PubMed ID: 25769054
    [No Abstract]   [Full Text] [Related]  

  • 2. How many MSM in Europe could benefit from PrEP--a 9 billion Euro question?
    Kenyon CR; Osbak K
    Int J STD AIDS; 2015 Nov; 26(13):988-90. PubMed ID: 26490178
    [No Abstract]   [Full Text] [Related]  

  • 3. Current world literature.
    Curr Opin HIV AIDS; 2010 May; 5(3):261-3. PubMed ID: 20539084
    [No Abstract]   [Full Text] [Related]  

  • 4. Financial barrier to HIV treatment.
    Aust Nurs Midwifery J; 2014 Mar; 21(8):7. PubMed ID: 24724191
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV Antiretroviral Therapy Costs in the United States, 2012-2018.
    McCann NC; Horn TH; Hyle EP; Walensky RP
    JAMA Intern Med; 2020 Apr; 180(4):601-603. PubMed ID: 32011622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the variation in costs among HIV primary care providers.
    Gilman BH; Green JC
    AIDS Care; 2008 Oct; 20(9):1050-6. PubMed ID: 18825514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seizing the opportunity to capitalise on the growing access to HIV treatment to expand HIV prevention.
    Gayle H; Lange JM
    Lancet; 2004 Jul 3-9; 364(9428):6-8. PubMed ID: 15234835
    [No Abstract]   [Full Text] [Related]  

  • 8. Effectiveness and cost effectiveness of early and late prevention of HIV/AIDS progression with antiretrovirals or antibiotics in Southern African adults.
    Bachmann MO
    AIDS Care; 2006 Feb; 18(2):109-20. PubMed ID: 16338768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lifetime cost of current human immunodeficiency virus care in the United States.
    Schackman BR; Gebo KA; Walensky RP; Losina E; Muccio T; Sax PE; Weinstein MC; Seage GR; Moore RD; Freedberg KA
    Med Care; 2006 Nov; 44(11):990-7. PubMed ID: 17063130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cost of Illness of HIV Patients under Anteretroviral Therapy in Germany - Results of the 48-Week Interim Analysis of the Prospective Multicentre Observational Study 'CORSAR'].
    Kuhlmann A; Mittendorf T; Hower M; Heiken H; Gerschmann S; Klauke S; Lutz T; Bogner J; Degen O; van Lunzen J; Bachmann C; Stellbrink HJ; Schmidt W; Leistner I; Mahlich J; Ranneberg B; Stoll M
    Gesundheitswesen; 2015 Jun; 77(6):e133-42. PubMed ID: 25247761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The obligation to provide antiretroviral treatment in HIV prevention trials.
    Lo B; Padian N; Barnes M
    AIDS; 2007 Jun; 21(10):1229-31. PubMed ID: 17545698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routine screening for HIV infection--timely and cost-effective.
    Bozzette SA
    N Engl J Med; 2005 Feb; 352(6):620-1. PubMed ID: 15703428
    [No Abstract]   [Full Text] [Related]  

  • 13. Healthcare costs associated with antiretroviral adherence among medicaid patients.
    Pruitt Z; Robst J; Langland-Orban B; Brooks RG
    Appl Health Econ Health Policy; 2015 Feb; 13(1):69-80. PubMed ID: 25403718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV/AIDS, development, and resources: perspective from a South African physician.
    Muller FJ
    J Int Assoc Physicians AIDS Care (Chic); 2003; 2(4):131-2. PubMed ID: 14986513
    [No Abstract]   [Full Text] [Related]  

  • 15. WHO urges developing countries to invest in health.
    Kapp C
    Lancet; 2003 Nov; 362(9395):1557. PubMed ID: 14626996
    [No Abstract]   [Full Text] [Related]  

  • 16. Investing wisely in HIV/AIDS.
    Lancet Infect Dis; 2012 Jan; 12(1):1. PubMed ID: 22192123
    [No Abstract]   [Full Text] [Related]  

  • 17. [Costs and adherence to antiretroviral treatment].
    Ventura-Cerdá JM; Ayago-Flores D; Vicente-Escrig E; Mollá-Cantavella S; Alós-Almiñana M
    Farm Hosp; 2010; 34(6):284-92. PubMed ID: 20692861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Price of second-line antiretroviral therapy reduced.
    Wkly Epidemiol Rec; 2007 Apr; 82(17):151. PubMed ID: 17465077
    [No Abstract]   [Full Text] [Related]  

  • 19. Scaling up antiretroviral treatment in resource-poor settings.
    Ellman T; Ford N
    Lancet; 2006 Aug; 368(9534):445-6. PubMed ID: 16890818
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinton brokers deal to lower price of antiretrovirals.
    Abimbola S
    BMJ; 2007 May; 334(7602):1026. PubMed ID: 17510129
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.